The Global Coronary Stents Market size is expected to reach $13.2 billion by 2024, rising at a market growth of 8.5% CAGR during the forecast period.
The demand for coronary stents can be attributed to growing incidences of cardiovascular disorders among the human population worldwide. Unhealthy lifestyle among working class has had a huge impact on the health. Due to unhealthy lifestyle among masses, the incidences of cardiovascular conditions have significantly increased over the years. Some of the leading causes of the condition are smoking, physical inactivity, and dietary changes among the masses. These lifestyle changes have led to greater possibility of hypertension, obesity, and blocks in arteries.
Global Coronary Stents Market Size
Based on Product Type, the Coronary Stents Market Size is segmented into Drug-eluting stents (DES), Bare-Metal Stents and Bioresorbable Vascular Scaffold. Drug-eluting stents (DES) are further classified into Polymer Based Coatings and Polymer Free Coatings. Polymer Free Coatings is segmented into Micro Structured Surface, Micro porous Surface, Slotted Tubular Surface and Nanoporous Surface. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.
Global Coronary Stents Market Share
The Coronary Stents Market Analysis report covers the analysis of key stake holders of the market. Key companies profiled in the report include ABBOTT, Terumo Medical Corporation, Medtronic Plc., B. Braun Melsungen AG, Boston Scientific Corporation, C.R. Bard, Inc., Cook Medical Incorporated, Johnson & Johnson, Biotronik SE & Co. KG, Biosensors International Group Ltd.
Scope of the Coronary Stents Market Analysis
Market Segmentation:
By Product Type
By Geography
Companies Profiled
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.